MICHELLE SANFORD: Open Payments
NPI 1811218076 · FARMINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 9 payments from 6 companies in 2025. Trend: 2023 $68 · 2024 $127 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $148 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| PFIZER INC. | 1 | $27 |
| Gilead Sciences, Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Novo Nordisk Inc | 1 | $17 |
Products named: CARDIOMEMS, LEQVIO, VYNDAQEL, Trodelvy, WAINUA, Wegovy.
Industry payments across CT — which companies pay providers there.
